MRAR - Maladies rares
Evaluation du potentiel thérapeutique de molécules candidates et suppression de la protéine pathologique dans l'ataxie spinocérebelleuse de type 7 (SCA7) – SCA7 therapy
Project coordination
Annie SITTLER (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 398,384 euros
Beginning and duration of the scientific project:
- 36 Months
